OS Therapies Inc
OS Therapies is a clinical-stage cancer immunotherapy company developing novel treatments for Osteosarcoma (OS) and other solid tumors. They focus on HER2-targeted therapies and OST-tADC, an Antibody Drug Conjugate platform. The company aims to bring the first new treatment for OS in over 30 years to market, and expand into other solid tumors.
Offisielt Register
AI Kvalitetsanalyse
Tillitsscore Detaljer
Snarveier
Nettside Høydepunkter
🌟 Lignende Pålitelige Bedrifter
Metagenomi, Inc.
Metagenomi is an in vivo genome editing company creating curative genetic medicines using proprietary technologies. They leverage metagenomics to discover editing tools potentially capable of correcting any type of genetic mutation. The company focuses on diseases with well-understood biology and clear regulatory pathways, and intends to expand their pipeline through genetic editing capabilities.
ARCTICZYMES TECHNOLOGIES ASA
ArcticZymes Technologies er et bioteknologiselskap som spesialiserer seg på utvikling og produksjon av enzymer. De tilbyr nukleaser for bioframstilling og molekylær diagnostikk, inkludert Saltaktive nukleaser (SAN). Selskapet er kjent for sine polymeraser og enzymer brukt i forskning og industrielle anvendelser.
ACD PHARMACEUTICALS AS
ACD Pharma is a Norwegian R&D company developing biocontrol products based on bacteriophages, focusing on combating harmful bacteria in animals and humans. They launched Custus®YRS, the world's first bacteriophage product for aquaculture. They collaborate with pharmaceutical and scientific teams to fight antibiotic resistance, extending their advancements across sectors.